SS

Sunita Shrivastava

Active Director Designated Partner DIN 10654439
DIN 10654439 First appointment Jun 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sunita Shrivastava

Data last updated:

Sunita Shrivastava is a Designated Partner at Mscians Drugs India Llp (since 2024).

DIN 10654439
Primary Designation Designated Partner
First Appointment 03 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner03 Jun 20242024Active

Board colleagues of Sunita Shrivastava

NameDINCompanyDesignation
Adity Sharma11219492Mscians Drugs India LlpDesignated Partner
Aryansh Khare10654440Mscians Drugs India LlpDesignated Partner
Sanjay Kumar Khare10654438Mscians Drugs India LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Mscians Drugs India Llp
Premium access

Shareholding and investment profile for Sunita Shrivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sunita Shrivastava

Sunita Shrivastava currently holds 1 directorship: Mscians Drugs India Llp (Designated Partner, since 03 Jun 2024).

Sunita Shrivastava was first appointed on 03 Jun 2024 as Designated Partner at Mscians Drugs India Llp.

The current boards of Sunita Shrivastava's companies include Adity Sharma (Mscians Drugs India Llp), Aryansh Khare (Mscians Drugs India Llp), Sanjay Kumar Khare (Mscians Drugs India Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available